Genomic diversity and meiotic recombination among isolates of the biotech yeast Komagataella phaffii (Pichia pastoris)
Abstract Background Komagataella phaffii is a yeast widely used in the pharmaceutical and biotechnology industries, and is one of the two species that were previously called Pichia pastoris. However, almost all laboratory work on K. phaffii has utilized strains derived from a single natural isolate,...
Main Authors: | Stephanie Braun-Galleani, Julie A. Dias, Aisling Y. Coughlan, Adam P. Ryan, Kevin P. Byrne, Kenneth H. Wolfe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Microbial Cell Factories |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12934-019-1260-4 |
Similar Items
-
Effect of Pyruvate Decarboxylase Knockout on Product Distribution Using Pichia pastoris (Komagataella phaffii) Engineered for Lactic Acid Production
by: Nadiele T. M. Melo, et al.
Published: (2018-02-01) -
Komagataella phaffii as Emerging Model Organism in Fundamental Research
by: Lukas Bernauer, et al.
Published: (2021-01-01) -
An effective combination of codon optimization, gene dosage, and process optimization for high-level production of fibrinolytic enzyme in Komagataella phaffii (Pichia pastoris)
by: Zhiqun Che, et al.
Published: (2020-12-01) -
Applications of recombinant Pichia pastoris in the healthcare industry
by: Daniel Weinacker, et al.
Published: (2013-12-01) -
Rationale‐based selection of optimal operating strategies and gene dosage impact on recombinant protein production in Komagataella phaffii (Pichia pastoris)
by: Miguel Angel Nieto‐Taype, et al.
Published: (2020-03-01)